Sterling Investment Advisors Ltd. Raises Stock Position in JPMorgan Chase & Co. $JPM

Sterling Investment Advisors Ltd. grew its holdings in JPMorgan Chase & Co. (NYSE:JPM) by 1.2% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 24,317 shares of the financial services provider’s stock after acquiring an additional 284 shares during the period. JPMorgan Chase & Co. comprises approximately 1.6% of Sterling Investment Advisors Ltd.’s holdings, making the stock its 18th biggest holding. Sterling Investment Advisors Ltd.’s holdings in JPMorgan Chase & Co. were worth $7,050,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in JPM. Brighton Jones LLC raised its stake in shares of JPMorgan Chase & Co. by 11.0% in the 4th quarter. Brighton Jones LLC now owns 48,732 shares of the financial services provider’s stock valued at $11,682,000 after acquiring an additional 4,841 shares during the period. Curat Global LLC purchased a new position in shares of JPMorgan Chase & Co. in the 1st quarter valued at $33,000. Procyon Advisors LLC raised its stake in shares of JPMorgan Chase & Co. by 0.6% in the 1st quarter. Procyon Advisors LLC now owns 90,497 shares of the financial services provider’s stock valued at $22,199,000 after acquiring an additional 564 shares during the period. MKT Advisors LLC raised its stake in shares of JPMorgan Chase & Co. by 3.3% in the 1st quarter. MKT Advisors LLC now owns 2,869 shares of the financial services provider’s stock valued at $704,000 after acquiring an additional 91 shares during the period. Finally, Sandbox Financial Partners LLC raised its stake in shares of JPMorgan Chase & Co. by 4.7% in the 1st quarter. Sandbox Financial Partners LLC now owns 5,946 shares of the financial services provider’s stock valued at $1,459,000 after acquiring an additional 267 shares during the period. Hedge funds and other institutional investors own 71.55% of the company’s stock.

Insider Activity at JPMorgan Chase & Co.

In other JPMorgan Chase & Co. news, Director Linda Bammann sold 9,500 shares of the business’s stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $297.94, for a total transaction of $2,830,430.00. Following the sale, the director directly owned 82,207 shares in the company, valued at approximately $24,492,753.58. The trade was a 10.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.47% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on JPM. Evercore ISI raised their target price on shares of JPMorgan Chase & Co. from $309.00 to $330.00 and gave the company an “outperform” rating in a research note on Tuesday. Bank of America raised their price target on shares of JPMorgan Chase & Co. from $330.00 to $340.00 and gave the company a “buy” rating in a report on Wednesday, July 16th. Deutsche Bank Aktiengesellschaft raised their price target on shares of JPMorgan Chase & Co. from $300.00 to $320.00 and gave the company a “hold” rating in a report on Tuesday, September 30th. Zacks Research lowered shares of JPMorgan Chase & Co. from a “strong-buy” rating to a “hold” rating in a report on Monday, September 8th. Finally, Morgan Stanley raised their price objective on shares of JPMorgan Chase & Co. from $298.00 to $336.00 and gave the stock an “equal weight” rating in a report on Monday, September 29th. Fifteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, JPMorgan Chase & Co. presently has an average rating of “Hold” and an average target price of $307.70.

JPMorgan Chase & Co. Trading Up 0.8%

JPMorgan Chase & Co. stock opened at $309.89 on Friday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 1.25. The firm has a 50-day moving average price of $300.67 and a two-hundred day moving average price of $274.72. The firm has a market capitalization of $852.11 billion, a price-to-earnings ratio of 15.90, a PEG ratio of 2.04 and a beta of 1.13. JPMorgan Chase & Co. has a 52-week low of $202.16 and a 52-week high of $318.01.

JPMorgan Chase & Co. (NYSE:JPM) last posted its earnings results on Tuesday, July 15th. The financial services provider reported $4.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.48 by $0.48. The firm had revenue of $44.91 billion during the quarter, compared to analyst estimates of $43.76 billion. JPMorgan Chase & Co. had a net margin of 20.52% and a return on equity of 16.93%. JPMorgan Chase & Co.’s revenue was down 10.5% on a year-over-year basis. During the same period in the previous year, the business posted $6.12 EPS. Sell-side analysts expect that JPMorgan Chase & Co. will post 18.1 earnings per share for the current year.

JPMorgan Chase & Co. Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Monday, October 6th will be given a dividend of $1.50 per share. This is a positive change from JPMorgan Chase & Co.’s previous quarterly dividend of $1.40. The ex-dividend date is Monday, October 6th. This represents a $6.00 dividend on an annualized basis and a dividend yield of 1.9%. JPMorgan Chase & Co.’s payout ratio is presently 28.73%.

JPMorgan Chase & Co. Company Profile

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate.